S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
Log in
NASDAQ:LIFE

aTyr Pharma Earnings Date, Estimates & History

$4.44
+0.12 (+2.78 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.21
Now: $4.44
$4.48
50-Day Range
$3.53
MA: $4.79
$8.06
52-Week Range
$2.13
Now: $4.44
$8.33
Volume523,937 shs
Average Volume1.17 million shs
Market Capitalization$45.22 million
P/E RatioN/A
Dividend YieldN/A
Beta2.17

Earnings

aTyr Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 25th, 2021 based off prior year's report dates.

aTyr Pharma Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

aTyr Pharma (NASDAQ:LIFE) Earnings Estimates

Current Year EPS Consensus Estimate: $-2.14 EPS
Next Year EPS Consensus Estimate: $-2.47 EPS

aTyr Pharma (NASDAQ LIFE) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/25/2021
(Estimated)
       
11/17/20209/30/2020($0.74)($0.68)($0.68)$0.16 million$0.15 millionTranscript
8/13/20206/30/2020($0.73)($0.69)($0.69)$0.40 million$0.19 millionTranscript
5/12/20203/31/2020($0.18)$0.25$0.25$4.40 million$8.07 millionTranscript
3/26/202012/31/2019($1.59)($1.54)($1.54)$0.09 million$0.14 millionTranscript
11/14/2019Q3 2019($1.43)($1.47)($1.47)$0.06 million$0.18 millionTranscript
8/14/2019Q2 2019($2.74)($1.80)($1.80)$0.09 millionN/A
5/13/20193/31/2019($3.22)($2.52)($0.18)Transcript
3/25/2019Q4($3.0380)($2.94)($0.21)Transcript
11/13/2018Q3 2018($4.20)($3.36)($0.24)N/A
8/14/2018Q2 2018($4.76)($4.90)($0.35)N/A
5/14/2018Q1($4.90)($5.04)($0.36)Transcript
3/19/2018Q4 2017($6.02)($5.46)($0.39)N/A
11/14/2017Q3 2017($7.00)($6.02)($0.43)N/A
8/14/2017Q2 2017($7.98)($7.14)($0.51)N/A
5/11/2017Q1 2017($6.9580)($7.84)($0.56)N/A
3/16/2017Q4 2016($8.54)($7.42)($0.53)N/A
11/14/2016Q3 2016($9.38)($8.12)($0.58)N/A
8/10/2016Q216($9.94)($9.10)($0.65)N/A
5/11/2016Q1($9.80)($9.52)($0.68)N/A
3/30/2016Q4($7.28)($9.80)($0.70)N/A
11/10/2015Q3($6.72)($6.72)($0.48)N/A
8/12/2015Q215($7.42)($10.36)($0.74)N/A
6/18/2015Q115($5.74)($5.32)($0.38)N/A
11/5/2013Q313$13.58$14.28$926.10 million$936.00 millionN/A
7/31/2013Q2 2013$13.44$10.08$952.06 million$944.00 millionTranscript
5/2/2013Q1 2013$14.56$14.98$958.56 million$963.00 millionTranscript
2/4/2013Q4 2012$15.54$15.54$988.85 million$998.90 millionTranscript
11/1/2012Q312$12.46$12.88$907.91 million$911.00 millionN/A
7/31/2012$13.58$13.44N/A
2/7/2012$14.56$14.84N/A
10/25/2011$12.32$13.16N/A
7/28/2011$13.30$12.46N/A
4/26/2011$11.90$11.90N/A
2/3/2011$12.18$12.60N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.